2026-08-11T11:57:58-04:00 2025-12-31 814412823 KUDISCH OSTER & COMPANY LLC 129 GROVE ST MONTCLAIR NJ 07042 990EZ 2025-09-09 394407731 FOXP1 MEDICAL RESEARCH FOUNDATION FOXP 7186447401 105 W 86TH STREET BOX 239 NEW YORK NY 100243412 MIKHAL ROMAN DIRECTOR,TREAS&PRES 7186447401 2026-07-30 true GREGG L KUDISCH CPA P00448688 9733387032 2026-08-11 2025 2025-03-06 01:10:19Z X X FOXP1RESEARCH.ORG X X 50000 X 50000 50000 17849 3049 20898 29102 29102 X 25201 6956 0 32157 3055 0 29102 X TO PROMOTE MEDICAL RESEARCH SEEKING TREATMENTS AND A CURE FOR FOXP1 SYNDROME AND RELATED DISORDERS AND TO ADVOCATE FOR FASTER PATHWAYS FROM DISCOVERY TO THERAPY, INCLUDING THROUGH A) FUNDING AND SUPPORT OF SCIENTIFIC STUDIES AND THERAPEUTIC DEVELOPMENTS, B) FOSTERING COLLABERATION AMONG RESEARCHERS, CLINICIANS, AND FAMILIES, AND C) OFFERING EDUCATION ABOUT FOXP1 GENE MUTATIONS AND RELATED DISORDERS, AND D) PROVIDING SUPPORT FOR THOSE AFFECTED BY FOXP1 GENE MUTATIONS. FUNDING AND SUPPORT OF SCIENTIFIC STUDIES AND THERAPEUTIC DEVELOPMENTS PROVIDED FOR THE INITIAL STAGES OF COLLABORATION AMONG RESEARCHERS AND CLINICIANS THROUGH THE ENGAGEMENT OF VARIOUS SCIENTIFIC CONSULTING BUSINESSES. 14794 PROVIDED FOR THE INITIAL STAGES OF OFFERING EDUCATION BY WORKING WITH PROFESSIONALS TO CREATE A WEBSITE FOR DISSEMINATION OF RESEARCH INFORMATION CONCERNING FOXP1 GENE MUTATIONS. 2400 17194 SAMIT DASGUPTA DIRECTOR & P 40.00 0 MIKHAL ROMAN DIRECTOR,TRE 40.00 0 UMESH SHANKAR DIRECTOR & S 1.00 0 false false false false false false false false false NY NC MIKHAL ROMAN 105 W 86TH STREET BOX 239 NEW YORK NY 100243412 7186447401 false false false false false false false false false false false NONE NONE true X 50000 50000 50000 50000 48000 2000 50000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990-EZ, PART I, LINE 16 EXPENSES OFFICE EXPENSE 30 BANK CHARGES 35 WEB DESIGN FEES-WEBSITE 2,500 FILING FEES 484 TOTAL 3,049 FORM 990-EZ, PART II, LINE 24 PREPAID EXPENSES AND DEFERRED CHARGES 0 6,956 TOTAL 0 6,956 FORM 990-EZ, PART II, LINE 26 ACCOUNTS PAYABLE AND ACCRUED EXPENSES 0 3,055 FORM 990-EZ, PART III TO PROMOTE MEDICAL RESEARCH SEEKING TREATMENTS AND A CURE FOR FOXP1 SYNDROME AND RELATED DISORDERS AND TO ADVOCATE FOR FASTER PATHWAYS FROM DISCOVERY TO THERAPY, INCLUDING THROUGH A) FUNDING AND SUPPORT OF SCIENTIFIC STUDIES AND THERAPEUTIC DEVELOPMENTS, B) FOSTERING COLLABERATION AMONG RESEARCHERS, CLINICIANS, AND FAMILIES, AND C) OFFERING EDUCATION ABOUT FOXP1 GENE MUTATIONS AND RELATED DISORDERS, AND D) PROVIDING SUPPORT FOR THOSE AFFECTED BY FOXP1 GENE MUTATIONS.